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Abstract
Background
Iron deficiency anemia (IDA) is a common extra-intestinal manifestation of celiac disease
(CD). Little is known about the frequency with which primary care physicians (PCPs) test for
CD in patients with IDA. We aimed to describe how PCPs approach testing for CD in asymp-
tomatic patients with IDA.
Methods
We electronically distributed a survey to PCPs who are members of the American
College of Physicians. Respondents were asked whether they would test for CD (serologic
testing, refer for esophagogastroduodenoscopy [EGD], or refer to GI) in hypothetical
patients with new IDA, including: (1) a young Caucasian man, (2) a premenopausal Cauca-
sian woman, (3) an elderly Caucasian man, and (4) a young African American man. These
scenarios were chosen to assess for differences in testing for CD based on age, gender,
and race. Multivariable logistic regression was used to identify independent predictors of
testing.
Results
Testing for CD varied significantly according to patient characteristics, with young Cauca-
sian men being the most frequently tested (61% of respondents reporting they would per-
form serologic testing in this subgroup (p<0.001)). Contrary to guideline recommendations,
80% of respondents reported they would definitely or probably start a patient with positive
serologies for CD on a gluten free diet prior to confirmatory upper endoscopy.
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Conclusions
PCPs are under-testing for CD in patients with IDA, regardless of age, gender, race, or post-
menopausal status. The majority of PCPs surveyed reported they do not strictly adhere to
established guidelines regarding a confirmatory duodenal biopsy in a patient with positive
serology for CD.
Introduction
Celiac disease (CD) is an immune-mediated disorder triggered by exposure to dietary gluten
in genetically susceptible individuals. Previously, CD had been described predominantly as a
pediatric disorder; however, it is now increasingly recognized in adult patients, including the
elderly [1]. CD currently affects around 1% of the general population [2–6], and the prevalence
of CD appears to be increasing over time [1]. Although CD is thought to primarily affect non-
Hispanic Caucasians, other ethnicities can also develop CD, though the data on prevalence is
less robust [7,8].
Despite an overall increase in awareness, CD is still an under-diagnosed condition [9].
Indeed, the diagnosis is often delayed by years, which may reflect the non-specific symptoms
of CD and a low index of suspicion by providers. Patients can present with subtle, extra-intesti-
nal manifestations of disease, such as iron deficiency anemia (IDA) or osteoporosis. IDA rep-
resents the most common extra-intestinal manifestation and has been reported to occur in up
to 50% of patients diagnosed with subclinical disease [5,10–12]. Conversely, CD has been rec-
ognized as the underlying etiology of unexplained IDA in up to 7% of encountered cases
[10,11,13–16]. As a result, clinical practice guidelines from groups such as the American Acad-
emy of Family Physicians (AAFP) and the British Society of Gastroenterology (BSG) suggest
testing for CD in patients with unexplained IDA. Yet, we know little about how physicians cur-
rently approach work-up in such patients [17,18].
The purpose of this study was to describe how primary care physicians (PCPs) approach
the work-up of unexplained IDA in asymptomatic and minimally symptomatic patients, and
more specifically, to determine the frequency of testing for CD in this population of patients.
In addition, we sought to identify which patient- and physician-level factors predicted the use
of testing for CD.
Methods
Overview
We developed a 25-item multiple-choice survey to assess how PCPs work-up unexplained
IDA. The primary outcome was frequency of testing for CD with: (1) serologic testing; or, (2)
any testing (which included serologic testing, “open access” EGD, or referral to gastroenterol-
ogy). Additionally, because initiation of a gluten free diet (GFD) will reduce the sensitivity of
duodenal biopsies for disease confirmation, we also sought to quantify the proportion of
respondents who would confirm the diagnosis of CD with a duodenal biopsy prior to initiation
of a GFD.
Survey design
The survey was developed by study team members (MS, SS) and reviewed by and modified
based on input from a survey design team at the University of Michigan. The survey was then
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pilot tested among five physicians prior to distribution. Feedback from these providers was
used to further modify the survey instrument.
The survey comprised two main sections: (1) four hypothetical patient scenarios regarding
the work-up of patients with newly diagnosed IDA; and, (2) questions specifically related to
the work-up and management of CD. Hypothetical patient scenarios included a 21-year-old
Caucasian man, a 29-year-old African American man, a 31-year-old Caucasian woman, and a
77-year-old Caucasian man. These scenarios were selected to maximize variation on age, gen-
der, and race. For each respondent, the first scenario presented was that of the 21-year-old
Caucasian man (an individual who is at high risk for CD as a cause for his IDA due to young
age, Caucasian race, and low likelihood of alternative diagnosis). The order of subsequent sce-
narios was randomized to minimize bias related to the subject becoming familiar with the for-
mat of the scenarios (which were identical with the exception of age, gender, and race). The
first scenario read as follows: “A 21-year-old Caucasian man comes to see you complaining of
generalized fatigue with no other associated symptoms. Labs show a hemoglobin of 11.1 g/dL
with a mean corpuscular volume (MCV) of 72.3 fL. Iron studies reveal new iron deficiency
anemia: iron level 6 ug/dL, ferritin 8 ng/mL, transferrin saturation 2%. He denies any overt
bleeding. Currently, he is back for a follow up visit to discuss his results.”
In each scenario, surveyed physicians were asked which tests they would order or perform
at an initial clinic visit to further work-up IDA. Options included urinalysis, iron supplemen-
tation with plans to repeat iron studies in several months, fecal occult blood testing, serologic
studies for CD, referral for “open access” colonoscopy (referring directly without seeing a
gastroenterologist first), referral for “open access” esophagogastroduodenoscopy (EGD), refer-
ral to hematology, or referral to gastroenterology. Participants were instructed to select all
options that might apply.
The second section consisted of questions related to the diagnosis and management of CD.
For instance, respondents were questioned about additional work-up in a patient with positive
serologic testing for CD. Other questions asked about the approach to prescription of a gluten
free diet (GFD) and referral patterns for further management of newly diagnosed CD. Data
were also collected on respondent demographics, including: (1) age, gender, and race; (2) med-
ical school affiliation; (3) years in clinical practice; (4) board certification status; and, (5) prac-
tice characteristics.
Study population
The finalized survey was distributed electronically via the American College of Physicians
(ACP) Research Center’s Internal Medicine Research panel. This panel is a representative
group of ACP members who have voluntarily agreed to participate in periodic physician sur-
veys. Participants receive points for completing surveys that may then be redeemed for gift
cards. All panel members were initially invited to complete the survey. Screening questions
were then used to exclude the following provider groups from the survey: (1) physician train-
ees; (2) retired physicians; (3) geriatricians; (4) hospitalists; and (5) physicians who spend less
than 25% of their time in clinical practice. Four reminder emails to complete the survey were
sent during the survey period of approximately three weeks. For this survey, respondents
received 100 points (corresponding to $10).
Statistical analysis
Survey responses were summarized using simple proportions. Multivariable logistic regression
was used to identify independent predictors of testing for celiac disease. Odds ratios (ORs) and
confidence intervals (CI) were calculated. Statistical significance was defined as a two-sided p-
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value of<0.05 for all tests. Analyses were performed using SPSS (version 21, IBM Corp.,
Armonk, NY) and Stata 13 (State Corp, College Station, TX).
Institutional review board
This study was deemed to meet the criteria for exemption by the University of Michigan Insti-
tutional Review Board (IRB).
Results
Participant demographics
240 of 470 physicians completed the survey (51% response rate). The majority of respondents
were men (62%) and Caucasian (74%) (Table 1). More than half (56%) practiced in a private
office. Almost all (87%) spent more than half their time delivering primary care. Approxi-
mately half spent all of their clinical time in the outpatient setting (51%). The majority had
been in clinical practice for over 20 years (52%), and most were not affiliated with a medical
school (60%). Almost all respondents were board certified in Internal Medicine (98%). Addi-
tional characteristics of the study population are described in Table 1.
Initial approach to iron deficiency anemia and testing for celiac disease
The approach to IDA varied widely across scenarios (p<0.001, Table 2). For example, 70% of
respondents would use iron supplementation for several months in a premenopausal Cauca-
sian woman, while fewer than 40% would use a similar approach in a male patient. 50% would
refer an elderly man for open access colonoscopy, while fewer (6–12%) would refer a young
patient. Notably, few would refer for open access EGD.
Frequency of testing for CD (both serologic testing and any testing, defined as serologic
testing, upper endoscopy, and/or gastroenterology referral) also varied significantly according
to patient characteristics. Specifically, 61% of those surveyed would perform serologic testing
for CD in a young Caucasian man with IDA (77% would perform any testing), but only 18%
would send for serologic testing in an elderly Caucasian man (66% would perform “any” test-
ing). In addition, 43% of physicians would perform serologic testing for CD in a premeno-
pausal Caucasian woman and 48% in a young African American man (the rates for any testing
in these groups were 54% and 69%, respectively) (Fig 1).
In multivariable analysis, PCPs who were affiliated with an academic institution were more
likely to send for serologic testing in young Caucasian men with IDA (the demographic with
the highest pretest probability for CD) than PCPs who were not associated with an academic
institution (OR: 2.0, 95% CI: 1.13–3.69, p-value: 0.02) (Table 3). PCPs who had been in clinical
practice for 10 years or less were less likely to perform any testing for a young Caucasian man
with IDA than were PCPs who were in practice for more than 10 years (OR: 0.4, 95% CI: 0.16–
0.82, p-value: 0.01) (Table 4). No statistically significant association was found among a PCP’s
gender, race, practice setting, years in clinical practice, or the availability of open access endos-
copy and the frequency of serologic testing for CD. Similarly, a PCP’s gender, race, academic
affiliation, practice setting, and availability of open access endoscopy did not predict the fre-
quency of any testing for CD in patients with IDA.
Initial management of celiac disease
The majority of respondents (80%) would definitely (37%) or probably (43%) start a patient
with positive serologic testing for CD on a GFD prior to confirmatory EGD. Only 13% “proba-
bly would not” and only 7% “definitely would not” start a GFD immediately after a positive
PCPs undertesting for CD in IDA
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Table 1. Respondent demographics.
Physician Factor Respondents No (%); N = 240
Gender
Male 148 (61.7)
Female 92 (38.3)
Race
Caucasian 178 (74.2)
African American 5 (2.08)
Asian 44 (18.3)
Native Hawaiian or Pacific Islander 0 (0.00)
American Indian or Alaskan Native 0 (0.00)
Other 13 (5.42)
Board Certification in Internal Medicine
Yes 235 (97.9)
No 5 (2.08)
Instructor or Other Faculty at a Medical School
Yes 97 (40.4)
No 143 (59.6)
Patient Care Setting
All inpatient 3 (1.19)
Primarily inpatient with some outpatient 12 (4.74)
Primarily outpatient with some inpatient 100 (39.5)
All outpatient 129 (51.0)
Equal outpatient and inpatient 9 (3.56)
Practice Setting
Private Office 134 (55.8)
University-affiliated hospital 28 (11.7)
Community hospital 26 (10.8)
Managed Care Organization 14 (5.83)
Veterans Association 15 (6.25)
Other 23 (9.58)
Region of Practice
Rural 35 (14.6)
Suburban 124 (51.7)
Urban 81 (33.8)
No. Years in Clinical Practice
<5 years 23 (9.58)
5–10 years 32 (13.3)
11–15 years 25 (10.4)
16–20 years 35 (14.6)
>20 years 125 (52.1)
Percentage of Time Spent in Primary Care
None 3 (1.15%)
Less than 25% 6 (2.29%)
25–50% 25 (9.54%)
50% or more 228 (87.0%)
Use of Open-Access Endoscopy
Yes 130 (54.2)
No 110 (45.8)
https://doi.org/10.1371/journal.pone.0184754.t001
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serologic test (Table 5). The proportion of physicians who would send patients with a positive
serology to “open access” EGD was variable: 23% “definitely would,” 30% “probably would,”
39% “probably would not,” and 7% “definitely would not”. A majority of PCPs would consider
referring patients with positive CD serology to a gastroenterologist (34% “definitively would”
and 38% “probably would”) (Table 5). In addition, 65% of respondents would not consider
serologic testing in an elderly person with IDA, and 28% would not consider serologic testing
in a premenopausal woman.
Discussion
IDA is a common finding in clinical medicine and is the most common extra-intestinal mani-
festation of CD. However, data on the work-up of IDA in the primary care setting is limited.
We found that testing for CD varies widely according to patient demographics, but overall,
PCPs appear to underuse testing for CD in patients with IDA, regardless of the definition of
testing used. In the clinical scenarios described in our survey (young Caucasian man, elderly
Table 2. Hypothetical patient cases of IDA.
Patient Characteristics Iron
Supplements
Referral for
EGD
Referral for
Colonoscopy
Serologic Testing for
CD*
Referral to
Gastroenterology*
21-year-old Caucasian man 86 (34.7) 28 (11.3) 26 (10.5) 151 (60.9) 53 (21.4)
77-year-old Caucasian man 74 (30.2) 54 (22.0) 123 (50.2) 44 (18.0) 95 (38.8)
29-year-old African American
man
93 (38.3) 29 (11.9) 28 (11.5) 116 (47.7) 58 (23.9)
31-year-old Caucasian woman 170 (70.0) 16 (6.58) 15 (6.17) 105 (43.2) 35 (14.4)
Total number of PCPs responding in the affirmative to each survey treatment option. The number within each parenthesis indicates the percentage of total
respondents.
*p<0.001 across hypothetical patient cases
https://doi.org/10.1371/journal.pone.0184754.t002
Fig 1. What proportion of primary care physicians test for CD in a patient with unexplained IDA?.
https://doi.org/10.1371/journal.pone.0184754.g001
PCPs undertesting for CD in IDA
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Caucasian man, young African American man, and young Caucasian woman), PCPs only sent
serologic testing in 18–61% of patients. Perhaps appropriately, elderly Caucasian men were the
least likely to have serologic testing for CD performed (18%), while young Caucasian men
were the most likely to undergo serologic testing. However, even for the highest risk group
(young Caucasian men), only 61% of PCPs would obtain serologic testing for CD during the
initial evaluation of IDA. For young Caucasian women and young African American men, less
than half would send serologic testing. The proportion of PCPs who would test for CD in
unexplained IDA only modestly improved when considering the more inclusive definition of
any testing for CD (54–77%).
The majority of PCPs in our study would also immediately start their patients on a GFD after
positive serologic testing (38% definitely would and 42% probably would). Although adhering to
a GFD is important in treating and preventing complications from CD, it should not be initiated
prior to endoscopic evaluation, as serology alone is insufficient to confirm the disorder [19,20].
While a positive serologic test is suggestive of the diagnosis, sensitivity and specificity of testing
are variable across different laboratories (ranging from 63–93% and 96–100% respectfully) [19–
21]. Moreover, small intestinal biopsies should be performed while patients are on a gluten-con-
taining diet, as abstaining from gluten reduces the sensitivity of histology [19,22,23]. The results
from our study should therefore raise concern that a significant proportion of patients with posi-
tive CD serology are not undergoing the appropriate confirmatory testing.
Table 3. What physician factors predict serologic testing for CD in a young, Caucasian male?.
Unadjusted Adjusted
Physician Factor Odds Ratio 95% CI p value Odds Ratio 95% CI p value
Length in clinic practice
>20 years 1 1
16–20 years 1.5 0.68–3.34 0.32 1.5 0.65–3.42 0.35
11–15 years 1.8 0.69–4.55 0.23 1.5 0.56–3.97 0.43
 10 years 0.9 0.47–1.69 0.72 0.7 0.32–1.34 0.25
Gender
Female 1 1
Male 0.9 0.52–1.51 0.65 0.8 0.47–1.49 0.55
Race
Asian 1 1
African
American
0.7 0.11–4.67 0.71 0.6 0.09–4.59 0.65
Other 0.5 0.15–1.92 0.35 0.5 0.14–1.94 0.33
Caucasian 0.7 0.35–1.42 0.33 0.6 0.28–1.25 0.17
Academic Affiliation
No 1 1
Yes 1.9 1.10–3.28 0.02* 2.0 1.13–3.69 0.02*
Open Access Available
No 1 1
Yes 1.5 0.87–2.47 0.15 1.5 0.88–2.60 0.14
Practice Setting
Rural 1 1
Suburban 1.1 0.49–2.27 0.89 0.9 0.43–2.09 0.90
Urban 1.1 0.48–2.42 0.86 0.8 0.33–1.83 0.56
*Denotes Statistical Significance
https://doi.org/10.1371/journal.pone.0184754.t003
PCPs undertesting for CD in IDA
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To the best of our knowledge, this study is the first of its kind to assess PCPs’ awareness of
CD as a potential cause of IDA, as well as determine how diagnostic evaluation is pursued in
this setting. A recent study published by Smukalla, et al, surveyed practicing hematologists to
assess how often they consider CD as a cause of IDA and order the appropriate serologic test-
ing. However, this differs from our current work, as PCPs (who see the vast majority of
patients with IDA) were not included in this study [24]. In accordance with our findings, Smu-
kalla et al found that hematologists do not routinely screen patients with IDA for CD, regard-
less of specific patient factors such as age, gender, race, or postmenopausal status. Contrary to
our findings that PCPs with fewer years in clinical practice were less likely to screen for CD,
the authors of this particular study found that hematologists who recently completed fellow-
ship training were more likely to screen for CD. These findings were postulated to be
Table 4. What factors predict “any” testing for CD (serology +/- referral for EGD +/- referral to GI) in a young, Caucasian male?.
Unadjusted Adjusted
Physician Factor Odds Ratio 95% CI p value Odds Ratio 95% CI p value
Length in clinic practice
>20 years 1 1
16–20 years 1.00 0.39–2.55 1.00 0.9 0.35–2.39 0.85
11–15 years 1.31 0.41–4.17 0.65 1.1 0.33–3.60 0.89
 10 years 0.51 0.25–1.05 0.07 0.4 0.16–0.82 0.01*
Gender
Female 1 1
Male 0.93 0.50–1.74 0.82 0.8 0.39–1.54 0.48
Race
Asian 1 1
African
American
0.28 0.04–2.02 0.21 0.2 0.03–1.91 0.18
Other 0.63 0.14–2.89 0.55 0.5 0.10–2.37 0.37
Caucasian 0.61 0.25–1.48 0.27 0.5 0.17–1.15 0.09
Academic Affiliation
No 1
Yes 1.48 0.78–2.79 0.23 1.6 0.79–3.12 0.19
Open Access Available
No 1
Yes 1.13 0.62–2.07 0.70 1.3 0.66–2.36 0.5
Practice Setting
Rural 1 1
Suburban 1.44 0.62–3.36 0.40 1.4 0.60–3.39 0.42
Urban 1.51 0.61–3.73 0.38 1.3 0.49–3.41 0.61
https://doi.org/10.1371/journal.pone.0184754.t004
Table 5. Questions pertaining to positive CD serology in IDA work-up.
Definitely Would Probably Would Probably Would Not Definitely Would Not
Immediately Start Gluten Free Diet 90 (37.5) 103 (42.9) 31 (12.9) 16 (6.67)
Open Access EGD 56 (23.3) 73 (30.4) 94 (39.2) 17 (7.08)
Referral to Gastroenterologist 82 (34.2) 90 (37.5) 61 (25.4) 7 (2.92)
Total number of PCPs responding in the affirmative to each survey treatment option. The number within each parenthesis indicates the percentage of total
respondents.
https://doi.org/10.1371/journal.pone.0184754.t005
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secondary to the recent increase in recognition of CD [24]. Overall, the conclusions that hema-
tologists under-recognize CD as a potential cause of IDA parallel our results from the primary
care setting.
There were several limitations to our study. First, the sample size was relatively small, limit-
ing our ability to draw statistical inferences. Additionally, the response rate was modest at
51%, which had the potential to introduce nonresponse bias. However, given that we surveyed
a panel of physicians specifically designed to be representative of ACP members, we feel that
our data fairly represent the practices of high-performing PCPs. Another limitation is difficulty
in assessing whether physicians’ responses to a survey truly depict their actions in clinical prac-
tice. Future studies could examine actual use of testing for CD as opposed to self-report,
though rates are likely to be lower than those reported in our study due to lack of completion
of ordered testing.
In conclusion, PCPs are under-testing for CD in patients with IDA, regardless of age, gen-
der, race, or postmenopausal status. In addition, the majority of physicians may not be strictly
adhering to established guidelines regarding the diagnosis and management of CD, including
confirmation of positive serologic testing with a duodenal biopsy while on a gluten-containing
diet. Efforts to better educate PCPs on the importance of testing and work-up of IDA and CD
are warranted.
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